Literature DB >> 31740798

RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions.

Johannes Schwerk1, Frank W Soveg1, Andrew P Ryan2, Kerri R Thomas1, Lauren D Hatfield1, Snehal Ozarkar1, Adriana Forero1, Alison M Kell1, Justin A Roby1, Lomon So1,3, Jennifer L Hyde4, Michael Gale1,5, Matthew D Daugherty6, Ram Savan7,8.   

Abstract

The initial response to viral infection is anticipatory, with host antiviral restriction factors and pathogen sensors constantly surveying the cell to rapidly mount an antiviral response through the synthesis and downstream activity of interferons. After pathogen clearance, the host's ability to resolve this antiviral response and return to homeostasis is critical. Here, we found that isoforms of the RNA-binding protein ZAP functioned as both a direct antiviral restriction factor and an interferon-resolution factor. The short isoform of ZAP bound to and mediated the degradation of several host interferon messenger RNAs, and thus acted as a negative feedback regulator of the interferon response. In contrast, the long isoform of ZAP had antiviral functions and did not regulate interferon. The two isoforms contained identical RNA-targeting domains, but differences in their intracellular localization modulated specificity for host versus viral RNA, which resulted in disparate effects on viral replication during the innate immune response.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31740798      PMCID: PMC7240801          DOI: 10.1038/s41590-019-0527-6

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  45 in total

1.  Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein.

Authors:  Guangxia Gao; Xuemin Guo; Stephen P Goff
Journal:  Science       Date:  2002-09-06       Impact factor: 47.728

Review 2.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

Review 3.  Post-transcriptional regulation of interferons and their signaling pathways.

Authors:  Ram Savan
Journal:  J Interferon Cytokine Res       Date:  2014-04-04       Impact factor: 2.607

4.  Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling.

Authors:  Abigail Jarret; Adelle P McFarland; Stacy M Horner; Alison Kell; Johannes Schwerk; MeeAe Hong; Samantha Badil; Rochelle C Joslyn; Darren P Baker; Mary Carrington; Curt H Hagedorn; Michael Gale; Ram Savan
Journal:  Nat Med       Date:  2016-11-14       Impact factor: 53.440

Review 5.  Mx GTPases: dynamin-like antiviral machines of innate immunity.

Authors:  Otto Haller; Peter Staeheli; Martin Schwemmle; Georg Kochs
Journal:  Trends Microbiol       Date:  2015-01-06       Impact factor: 17.079

Review 6.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

7.  Expression of the zinc-finger antiviral protein inhibits alphavirus replication.

Authors:  Matthew J Bick; John-William N Carroll; Guangxia Gao; Stephen P Goff; Charles M Rice; Margaret R MacDonald
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

Review 9.  The broad-spectrum antiviral functions of IFIT and IFITM proteins.

Authors:  Michael S Diamond; Michael Farzan
Journal:  Nat Rev Immunol       Date:  2012-12-14       Impact factor: 53.106

10.  The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs.

Authors:  Adelle P McFarland; Stacy M Horner; Abigail Jarret; Rochelle C Joslyn; Eckart Bindewald; Bruce A Shapiro; Don A Delker; Curt H Hagedorn; Mary Carrington; Michael Gale; Ram Savan
Journal:  Nat Immunol       Date:  2013-11-17       Impact factor: 25.606

View more
  31 in total

Review 1.  RNA regulatory mechanisms that control antiviral innate immunity.

Authors:  Nandan S Gokhale; Julian R Smith; Rachel D Van Gelder; Ram Savan
Journal:  Immunol Rev       Date:  2021-08-17       Impact factor: 12.988

Review 2.  The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2.

Authors:  Saba R Aliyari; Natalie Quanquin; Olivier Pernet; Shilei Zhang; Lulan Wang; Genhong Cheng
Journal:  Pathogens       Date:  2022-05-03

3.  The Role of ZAP and TRIM25 RNA Binding in Restricting Viral Translation.

Authors:  Emily Yang; LeAnn P Nguyen; Carlyn A Wisherop; Ryan L Kan; Melody M H Li
Journal:  Front Cell Infect Microbiol       Date:  2022-06-21       Impact factor: 6.073

4.  Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency.

Authors:  Stefano Vavassori; Janet Chou; Laura Eva Faletti; Veronika Haunerdinger; Lennart Opitz; Pascal Joset; Christopher J Fraser; Seraina Prader; Xianfei Gao; Luise A Schuch; Matias Wagner; Julia Hoefele; Maria Elena Maccari; Ying Zhu; George Elakis; Michael T Gabbett; Maria Forstner; Heymut Omran; Thomas Kaiser; Christina Kessler; Heike Olbrich; Patrick Frosk; Abduarahman Almutairi; Craig D Platt; Megan Elkins; Sabrina Weeks; Tamar Rubin; Raquel Planas; Tommaso Marchetti; Danil Koovely; Verena Klämbt; Neveen A Soliman; Sandra von Hardenberg; Christian Klemann; Ulrich Baumann; Dominic Lenz; Andreas Klein-Franke; Martin Schwemmle; Michael Huber; Ekkehard Sturm; Steffen Hartleif; Karsten Häffner; Charlotte Gimpel; Barbara Brotschi; Guido Laube; Tayfun Güngör; Michael F Buckley; Raimund Kottke; Christian Staufner; Friedhelm Hildebrandt; Simone Reu-Hofer; Solange Moll; Achim Weber; Hundeep Kaur; Stephan Ehl; Sebastian Hiller; Raif Geha; Tony Roscioli; Matthias Griese; Jana Pachlopnik Schmid
Journal:  J Allergy Clin Immunol       Date:  2021-04-17       Impact factor: 10.793

5.  The Zinc Finger Antiviral Protein ZAP Restricts Human Cytomegalovirus and Selectively Binds and Destabilizes Viral UL4/UL5 Transcripts.

Authors:  Ana Cristina Gonzalez-Perez; Markus Stempel; Emanuel Wyler; Christian Urban; Antonio Piras; Thomas Hennig; Sabina Ganskih; Yuanjie Wei; Albert Heim; Markus Landthaler; Andreas Pichlmair; Lars Dölken; Mathias Munschauer; Florian Erhard; Melanie M Brinkmann
Journal:  mBio       Date:  2021-05-04       Impact factor: 7.867

Review 6.  PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis.

Authors:  Dae-Seok Kim; Sridevi Challa; Aarin Jones; W Lee Kraus
Journal:  Genes Dev       Date:  2020-02-06       Impact factor: 11.361

Review 7.  Cellular Factors Targeting HIV-1 Transcription and Viral RNA Transcripts.

Authors:  Rayhane Nchioua; Matteo Bosso; Dorota Kmiec; Frank Kirchhoff
Journal:  Viruses       Date:  2020-04-29       Impact factor: 5.048

Review 8.  The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions.

Authors:  Anthony R Fehr; Sasha A Singh; Catherine M Kerr; Shin Mukai; Hideyuki Higashi; Masanori Aikawa
Journal:  Genes Dev       Date:  2020-02-06       Impact factor: 11.361

9.  Extreme Genomic CpG Deficiency in SARS-CoV-2 and Evasion of Host Antiviral Defense.

Authors:  Xuhua Xia
Journal:  Mol Biol Evol       Date:  2020-09-01       Impact factor: 16.240

10.  Endomembrane targeting of human OAS1 p46 augments antiviral activity.

Authors:  Frank W Soveg; Johannes Schwerk; Nandan S Gokhale; Karen Cerosaletti; Julian R Smith; Erola Pairo-Castineira; Alison M Kell; Adriana Forero; Shivam A Zaver; Katharina Esser-Nobis; Justin A Roby; Tien-Ying Hsiang; Snehal Ozarkar; Jonathan M Clingan; Eileen T McAnarney; Amy El Stone; Uma Malhotra; Cate Speake; Joseph Perez; Chiraag Balu; Eric J Allenspach; Jennifer L Hyde; Vineet D Menachery; Saumendra N Sarkar; Joshua J Woodward; Daniel B Stetson; John Kenneth Baillie; Jane H Buckner; Michael Gale; Ram Savan
Journal:  Elife       Date:  2021-08-03       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.